WuXi AppTec is a global company that offers a comprehensive range of research and development (R&D) and manufacturing services to the pharmaceutical and healthcare industry. With operations across Asia, Europe, and North America, they provide innovative solutions that enable companies to advance discoveries and deliver groundbreaking treatments to patients. Their integrated services include chemistry drug development, biology discovery, preclinical testing, clinical research, and cell and gene therapies, helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions.
WuXi AppTec's open-access platform has garnered recognition, with an AA ESG rating from MSCI in 2023. This platform enables over 6,000 customers from more than 30 countries to access their services and work towards the vision that every drug can be made and every disease can be treated. With a focus on integrity, dedication, and doing the right thing, WuXi AppTec is committed to enabling innovation and driving advancements in the global pharmaceutical and healthcare industry.
Generated from the website